Earlier this year, I reviewed Lemonade (NYSE: LMND ) and stated the business was a "Buy." Despite being unprofitable, I like that this founder-led business is revolutionizing the insurance industry with their AI-first approach.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it ...